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Abstract
A 5 year old girl with thoracic empyema developed a scarlatiniform rash and acral desquamation.
Cultures from blood, throat, and pleural fluid all grew Streptococcus pyogenes, a common etiologic
agent of pediatric thoracic empyema. The presence of a scarlatiniform rash and acral desquamation
in children with a thoracic empyema may help identify the causative organism.
Background
The incidence of thoracic empyema complicating bacte-
rial pneumonia in children appears to be increasing[1,2];
it is commonly associated with Streptococcus pneumo-
niae, Staphylococcus aureus, and Streptococcus pyo-
genes[1,3-5]. Common signs and symptoms are non-
specific and include those related to the underlying pneu-
monia, with persistent fever and dyspnea. We report a 5
year old girl with thoracic empyema who developed a
scarlatiniform rash and acral desquamation, and review
the relevant literature.
Case report
The Integrated Scientific and Ethical Review Board of St
Vincent Catholic Medical Center exempted this case
report from review; parental consent was obtained for the
photographs. A 5 year old girl was admitted with 5 days of
fever to 40.0 degrees C, non-productive cough and vomit-
ing. There was poor oral intake for 3 days, with tachypnea
and left-sided chest pain for 2 days prior to admission. On
presentation she was in moderate respiratory distress with
intercostal retractions and nasal flaring. Her temperature
was 39.5 degrees C, heart rate 173/minute, respiratory rate
56/minute, blood pressure 95/64, and transcutaneous
oxygen saturation 91% on room air. Her pharynx was ery-
thematous without exudate. There were decreased breath
sounds, dullness to percussion over the lower 2/3 of the
left lung, and bronchial breath sounds above the level of
dullness. Laboratory results on admission included: white
blood cells 2.9 × 109/L (39% neutrophils, 23% bands and
14% lymphocytes), erythrocyte sedimentation rate (ESR)
75 mm/hr, sodium 132 mmol/L, blood urea nitrogen 45
mg/dL, creatinine 1.9 mg/dL, lactic acid 4.3 mmol/L, total
protein 4.7 g/dL, albumin 2.3 g/dlL, calcium 6.4 mg/dL,
lactate dehydrogenase 799 IU/L and anti-streptolysin
O<100 IU/mL, with an arterial blood gas (while she was
receiving oxygen): pH 7.32, PaCO2 16 mm Hg, PaO2 97
mmHg, and bicarbonate 8 mmol/L. A chest roentgeno-
gram showed complete opacity of the left hemithorax
with contralateral mediastinal shift (Figure 1A). Com-
puted tomography of the chest confirmed the presence of
a left pleural effusion with compressive atelectasis of the
left lung. Pleural fluid analysis revealed an exudate with
empyema (white blood cells 250,000/microL, glucose 24
mg/dL, total protein 2.5 g/dL, pH 7.22, lactate dehydroge-
nase> 21,500 IU/L, and gram stain with many gram posi-
tive cocci and few white blood cells). A thoracostomy tube
was inserted in the left hemithorax. She was treated with
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crystalloid fluids, oxygen and broad spectrum antibiotics
(vancomycin, imipenem, and clarithromycin).
On the second hospital day she developed a mildly ery-
thematous, sandpaper-like maculopapular rash over her
trunk. Three days later desquamation of her toes was
noted which progressed to involve her fingers and peri-
neum (Figure 2). Cultures of blood, throat, and pleural
fluid grew Streptococcus pyogenes, and antibiotics were
changed to penicillin G. Total thoracostomy tube drain-
age was 565 cc over 6 days. She continued to have daily
fever spikes to 40.6 degrees C. Repeat chest roentgeno-
gram on hospital day 6 (Figure 1B) showed improved aer-
ation in the left lung, and computed tomography scan on
hospital day 9 showed near complete resolution of the left
pleural fluid collection with interval appearance of a cav-
itary lesion in the left lung (2.5 × 1 cm) as well as several
small loculated fluid collections. Antibiotic coverage was
then broadened for several days, though follow-up blood
cultures were sterile. Fever and an elevated ESR with leu-
kocytosis persisted for 13 days after starting therapy.
The patient's condition gradually improved and she was
discharged home after 3 weeks, and received another 3
weeks of antibiotics at home. Four months later a repeat
chest roentgenogram was normal. The patient remained
healthy and asymptomatic at follow-up examination 1
year later.
Discussion
Efforts to isolate an organism are unsuccessful in at least
40 to 50% of all children with complicated parapneu-
monic effusions, including empyema[3,6,7]; Streptococ-
cus pyogenes is likely responsible in some of these
cases[3]. The association between thoracic empyema due
to Streptococcus pyogenes and scarlatiniform rash with
acral desquamation has been noted occasionally[8-10],
and we suggest that this association may help identify
Streptococcus pyogenes as the etiologic agent, particularly
when culture results are unavailable. The rash of scarlet
fever with subsequent acral desquamation is associated
not just with pharyngitis, but may also follow systemic
infections with Streptococcus pyogenes in children,
including pneumonia[9,11], bacteremia[12,13], septic
arthritis[13], Streptococcal toxic shock syndrome[14],
and necrotizing fasciitis and cellulitis[11]. Streptococcus
pyogenes toxins responsible for the rash and desquama-
tion are pyrogenic exotoxins produced by certain strains
of the bacteria. We found no reports of scarlatiniform rash
or acral desquamation associated with Staphylococcus
aureus or Streptococcus pneumoniae and pediatric tho-
racic empyema or pneumonia, though exfoliative toxins
produced by certain strains of Staphylococcus aureus may
also be responsible for a scarlatiniform rash and subse-
quent desquamation[15].
Resolution of pediatric thoracic empyema associated with
Streptococcus pyogenes is often slow, as in our patient:
fever, an elevated ESR, and leukocytosis may persist for
several weeks in spite of adequate treatment[16,17],
though the outcome is usually good. Initial management
of pediatric empyema includes tube thoracostomy and
empiric antibiotic therapy with antimicrobials effective
against Staphylococcus aureus and Streptococcus pneu-
moniae; these regimens generally provide adequate cover-
age of Streptococcus pyogenes. Further therapy for
pediatric thoracic empyema must be individualized, as
there is little consensus on the precise role for surgical
interventions, including video-assisted thoracoscopic sur-
gery, or fibrinolysis[2].
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Chest roentgenogram of child with thoracic empyema on  hospital days 1 (1A) and 6 (1B) Figure 1
Chest roentgenogram of child with thoracic 
empyema on hospital days 1 (1A) and 6 (1B).
Desquamation of the feet (2A, 2B) and hands (2C, 2D) Figure 2
Desquamation of the feet (2A, 2B) and hands (2C, 
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